Relay Therapeutics, Inc. RLAY Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s quick ratio?
- Relay Therapeutics, Inc. (RLAY) reported quick ratio of 22.1× in Q1 2026.
- How has Relay Therapeutics, Inc.'s quick ratio changed year-over-year?
- Relay Therapeutics, Inc.'s quick ratio increased by 10.9% year-over-year, from 20× to 22.1×.
- What is the long-term trend for Relay Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s quick ratio has grown at a -16.7% compound annual growth rate (CAGR), from 56.5× to 22.6×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.